Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GENB
GENB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GENB News
Cathie Wood Continues to Increase Stakes in Emerging Tech Stocks
23h ago
Fool
Cathie Wood Increases Holdings in Space Exploration and Others
23h ago
NASDAQ.COM
Nvidia Invests in Biotechnology Firm Generate Biomedicines
Jun 27 2026
Fool
Nvidia Invests in Biotech Firm Generate Biomedicines
Jun 27 2026
NASDAQ.COM
AdvanCell Signs Long-Term Lease, Innovation Park Fully Leased
Jun 22 2026
PRnewswire
HarbourVest Partners Acquires Stake in Generate Biomedicines
May 31 2026
Fool
HarbourVest Acquires 1.72 Million Shares of Generate Biomedicines
May 31 2026
NASDAQ.COM
Generate Biomedicines to Participate in Goldman Sachs Global Healthcare Conference
May 28 2026
PRnewswire
Generate Biomedicines Reports Q1 2026 Financial Results and Clinical Progress
May 07 2026
PRnewswire
Generate Biomedicines Reports Q1 Highlights and Progress
May 07 2026
Newsfilter
GENERATE BIOMEDICINES INC REPORTS $61.7 MILLION NET LOSS FOR Q1
May 07 2026
moomoo
GENERATE BIOMEDICINES, INC. ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER 2026 AND BUSINESS UPDATE
May 07 2026
moomoo
IPO Market Faces Delays Amid Volatility
Apr 01 2026
renaissancecapital
ARK Genomic Revolution ETF Underperforms
Mar 27 2026
NASDAQ.COM
IPO Market Faces Delays Amid Volatility
Mar 25 2026
renaissancecapital
Morgan Stanley Begins Coverage of Generate Biomedicines Inc with Overweight Rating and $20 Target Price
Mar 25 2026
moomoo
Show More News
